1-8 of 8
Paul H. Gumerlock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Primo N. Lara, Jr., Walter M. Stadler, Jeff Longmate, David I. Quinn, Jason Wexler, Marta Van Loan, Przemyslaw Twardowski, Paul H. Gumerlock, Nicholas J. Vogelzang, Everett E. Vokes, Heinz Josef Lenz, James H. Doroshow, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1556–1563.
https://doi.org/10.1158/1078-0432.CCR-05-2074
Published: 06 March 2006
View article titled, A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
Open the PDF for A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases in another window
Journal Articles

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Primo N. Lara, Jr, Philip C. Mack, Timothy Synold, Paul Frankel, Jeff Longmate, Paul H. Gumerlock, James H. Doroshow, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4444–4450.
https://doi.org/10.1158/1078-0432.CCR-04-2602
Published: 15 June 2005
View article titled, The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial
Open the PDF for The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial in another window
Journal Articles

Bronchioloalveolar Carcinoma: A Model for Investigating the Biology of Epidermal Growth Factor Receptor Inhibition

David R. Gandara, Howard West, Kari Chansky, Angela M. Davies, Derick H. M. Lau, John Crowley, Paul H. Gumerlock, Fred R. Hirsch, Wilbur A. Franklin
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4205s–4209s.
https://doi.org/10.1158/1078-0432.CCR-040012
Published: 15 June 2004
View article titled, Bronchioloalveolar Carcinoma: <subtitle>A Model for Investigating the Biology of Epidermal Growth Factor Receptor Inhibition</subtitle>
Open the PDF for Bronchioloalveolar Carcinoma: <subtitle>A Model for Investigating the Biology of Epidermal Growth Factor Receptor Inhibition</subtitle> in another window
Journal Articles

SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition

Primo N. Lara, Jr., David I. Quinn, Kim Margolin, Frederick J. Meyers, Jeff Longmate, Paul Frankel, Philip C. Mack, Corinne Turrell, Peter Valk, Jyotsna Rao, Penelope Buckley, Ted Wun, Robert Gosselin, Irina Galvin, Paul H. Gumerlock, Heinz Josef Lenz, James H. Doroshow, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4772–4781.
Published: 27 October 2003
View article titled, SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: <subtitle>A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition</subtitle>
Open the PDF for SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: <subtitle>A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition</subtitle> in another window
Journal Articles

Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: A California Cancer Consortium Phase I and Molecular Correlative Study

Primo N. Lara, Jr., Paul Frankel, Philip C. Mack, Paul H. Gumerlock, Irina Galvin, Cynthia L. Martel, Jeff Longmate, James H. Doroshow, Heinz Josef Lenz, Derick H. M. Lau, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (12): 4356–4362.
Published: 10 October 2003
View article titled, Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: <subtitle>A California Cancer Consortium Phase I and Molecular Correlative Study</subtitle>
Open the PDF for Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: <subtitle>A California Cancer Consortium Phase I and Molecular Correlative Study</subtitle> in another window
Journal Articles

Low ERCC1 Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer

Reginald V. N. Lord, Jan Brabender, David Gandara, Vicente Alberola, Carlos Camps, Manuel Domine, Felip Cardenal, José M. Sánchez, Paul H. Gumerlock, Miquel Tarón, José J. Sánchez, Kathleen D. Danenberg, Peter V. Danenberg, Rafael Rosell
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2286–2291.
Published: 01 July 2002
View article titled, Low <em>ERCC1</em> Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer
Open the PDF for Low <em>ERCC1</em> Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer in another window
Journal Articles

Effect of 67Cu-2IT-BAT-Lym-1 Therapy on BCL-2 Gene and Protein Expression in a Lymphoma Mouse Model

Linda A. Kroger, Sally J. DeNardo, Gerald L. DeNardo, Cheng Yi Xiong, Michelle D. Winthrop, Paul H. Gumerlock
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3010s–3014s.
Published: 01 October 1999
View article titled, Effect of <sup>67</sup>Cu-2IT-BAT-Lym-1 Therapy on <em>BCL-2</em> Gene and Protein Expression in a Lymphoma Mouse Model
Open the PDF for Effect of <sup>67</sup>Cu-2IT-BAT-Lym-1 Therapy on <em>BCL-2</em> Gene and Protein Expression in a Lymphoma Mouse Model in another window
Journal Articles

RB Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma

Philip C. Mack, David R. Gandara, Cai Bowen, Martin J. Edelman, Teresa Paglieroni, Joachim B. Schnier, Edward P. Gelmann, Paul H. Gumerlock
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2596–2604.
Published: 01 September 1999
View article titled, <em>RB</em> Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma
Open the PDF for <em>RB</em> Status as a Determinant of Response to UCN-01 in Non-Small Cell Lung Carcinoma in another window